DiscoverGencastNever Split the Science: Mark Boulding, Master Negotiator and Rare Disease Pioneer
Never Split the Science: Mark Boulding, Master Negotiator and Rare Disease Pioneer

Never Split the Science: Mark Boulding, Master Negotiator and Rare Disease Pioneer

Update: 2025-08-08
Share

Description

In this episode of GenCast, Mark Boulding—Executive Vice President and Chief Legal Officer at PTC Therapeutics—shares the secrets of how he went from law firm partner to the leadership team of a $4B public biotech company. 

Dive deep into strategic negotiations with real-world applications inspired by Chris Voss’ tactics from Never Split the Difference, drawn from Mark's experiences negotiating deals with big pharma. Learn how Mark’s unique approaches to the interpersonal aspects of business negotiations—when to take bold risks and how to manage information flows—have helped shape PTC’s pioneering journey in developing life-saving therapies for individuals living with rare diseases with significant funding from business development deals over more than two decades.

Discover how to use anchoring in non-quantitative contexts, deploy creative dispute resolution techniques like baseball arbitration, and create win-win scenarios using tactical empathy. Get an inside look at how Mark turned challenging situations into groundbreaking successful deals, making biotech negotiations not just a science, but an art form

Comments 
In Channel
Introduciendo Gencast

Introduciendo Gencast

2022-09-2608:06

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Never Split the Science: Mark Boulding, Master Negotiator and Rare Disease Pioneer

Never Split the Science: Mark Boulding, Master Negotiator and Rare Disease Pioneer

Sergio Mario Del Risco